Takahiro Matsuyama

Title: Takahiro Matsuyama: Innovator in Pharmaceutical Compounds

Introduction

Takahiro Matsuyama is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with glucocorticoid receptor agonist activity. With a total of 4 patents to his name, Matsuyama's work is paving the way for new therapeutic agents.

Latest Patents

Matsuyama's latest patents include innovative compounds such as [4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof. This invention relates to defined quinoxalin-2-one compounds or their pharmaceutically acceptable salts, hydrates, or solvates. These compounds exhibit glucocorticoid receptor agonist activity, making them useful as medicines, particularly for treating glucocorticoid receptor-related diseases. Another patent focuses on a novel [4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof, which also demonstrates similar therapeutic potential.

Career Highlights

Matsuyama is currently associated with Santen Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for various medical conditions.

Collaborations

Matsuyama has collaborated with notable colleagues such as Kenji Kawashima and Yusuke Yamazaki. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Takahiro Matsuyama's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His work on glucocorticoid receptor agonist compounds is paving the way for new therapeutic options.